Advances in Cancer Pathology

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: closed (30 September 2024) | Viewed by 1278

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pathology and Laboratory Medicine, University of California Irvine Medical Center, Orange, CA 92868, USA
Interests: general surgical pathology; genitourinary pathology; bone and soft tissue pathology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cancer pathology and pathogenesis refer to the study of the structural and functional changes that occur in cells and tissues affected by cancer. Pathologists analyze a wide spectrum of tissue samples, including biopsies, surgical resections, and cytopathology and autopsy samples, to make pathological diagnoses and provide important information to guide clinical treatment and management, which significantly improves a patient’s care and outcome. An enhanced awareness and recognition of novel pathologic entities and their underlying pathogenesis, as well as an in-depth understanding of the clinical behavior of diseases, will be very helpful for the development of targeted therapies. The aim of this Special Issue is to increase the awareness and understanding of pathologists and clinicians regarding pathologic diagnosis and its pitfalls to prevent over- or under-diagnoses and the overtreatment of a variety of human cancer types. Contributions to this Special Issue may be, therefore, related, but not limited to, immunohistochemical staining, fluorescence in situ hybridization (FISH), and DNA and RNA next-generation sequencing (NGS).

The article types of these submissions could be, but are not limited to, research articles, reviews, interesting images, or editorial comments.

I would like to invite you to submit your cutting-edge work and look forward to receiving your submissions.

Dr. Dong Ren
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pathological diagnosis and pitfall
  • immunohistochemical staining
  • molecular alteration underlying the diagnosis
  • cancer pathogenesis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

4 pages, 4616 KiB  
Interesting Images
Posttraumatic Cutaneous Meningioma with a “Meningiolipoma” Pattern Presenting as a Nasal Bridge Mass
by Dong Ren, Jerry Lou, Edward Kuan, Mari Perez-Rosendahl and William H. Yong
Diagnostics 2024, 14(16), 1731; https://doi.org/10.3390/diagnostics14161731 - 9 Aug 2024
Viewed by 929
Abstract
Meningiomas are tumors originating from arachnoid meningothelial cells. Occasionally, meningiomas are identified outside the central nervous system, and are referred to as extracranial meningiomas (EMs). The vast majority of EMs are an extension from an intracranial or intraspinal tumor. However, primary EMs may [...] Read more.
Meningiomas are tumors originating from arachnoid meningothelial cells. Occasionally, meningiomas are identified outside the central nervous system, and are referred to as extracranial meningiomas (EMs). The vast majority of EMs are an extension from an intracranial or intraspinal tumor. However, primary EMs may arise from extracranial sites with the most common sites being the skin and scalp subcutis, which are further categorized as cutaneous meningiomas (CMs). CMs are rare cutaneous tumors with similar ultrastructural and cytologic findings compared to those of intracranial meningiomas, but with a wide range of histologic differences. Therefore, an assessment using a panel of investigative tools, including imaging, histopathology, and immunohistochemistry, is required to determine the diagnosis of CMs. Here, we report the case of a 64-year-old gentleman presenting with a posttraumatic well-circumscribed superficial mass overlying the right nasal bridge. We are unable to identify other cases arising in the nasal bridge. Full article
(This article belongs to the Special Issue Advances in Cancer Pathology)
Show Figures

Figure 1

Back to TopTop